Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies (ticker BMNR) has turned into one of the loudest tickers in U.S. markets in late 2025. It’s no longer just a Bitcoin miner with immersion‑cooling hardware; it’s effectively an Ethereum super‑treasury with a public listing, options market,
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals plc (NASDAQ: BDRX) has turned into one of the most volatile biotech tickers of late 2025. After a sharp multi‑day surge driven by retail trading interest and momentum headlines, the stock has whipsawed back down, even as the
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme (Euronext Paris: ABVX, Nasdaq: ABVX) is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in
1 144 145 146 147 148 301
Go toTop